Alemtuzumab in the Treatment of Refractory Acute Rejection and Bronchiolitis Obliterans Syndrome After Human Lung Transplantation
Under a Creative Commons license
open archive
Key words:
Acute rejection
alemtuzumab
bronchiolitis obliterans syndrome
lung transplantation
Abbreviations
ATG
antithymocyte globulin
RAR
refractory acute rejection
BOS
bronchiolitis obliterans syndrome
Cited by (0)
Copyright © 2007 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.